Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
A financial benchmark comprises defined scope, transparent methodology, and objective performance metrics to enable consistent comparison and evaluation.
16,759 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Claude AI’s world predictions for two World Cup matches produced a mixed bag: a precise call in USA vs Australia and ...
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Politician Vance argues households are nominally richer by about $1,000, but economists say inflation has eaten into ...
January 2026 brings a shift in power toward buyers. Homes stay on the market longer, and sellers are more willing to ...
A leading market technician says the baton in leadership is shifting from mega-cap tech to cyclical sectors, with thr...
Winter demand and a growing data-center footprint push grid strain. The Trump administration accelerates a coal reviv...
Ford is aiming high with an AI-driven energy storage push. This article breaks down what that could mean for investor...
The 2026 software stock sell-off has traders buzzing, even as many companies post solid results. Is AI disruption fea...
A couple claiming Social Security at 62 invested the checks, but quarterly dividends pushed most of their benefits in...
Bandwidth Inc. released a mixed Q4 2025 report that sheds light on customer growth, margins, and the path to profitab...
Alphabet is branching far beyond search, funding a sweeping AI infrastructure push. This article unpacks why wall str...